Use of systemic corticosteroids does not reduce in-hospital mortality for patients with severe or critical coronavirus disease (COVID-19), which is in stark contrast to that observed in the RECOVERY clinical trial, according to a study in Wuhan, China.
Several medical procedures—such as mechanical ventilation, autopsies, and bronchoscopies—generate aerosols and come with a high risk of transmitting the novel coronavirus disease (COVID-19) to healthcare workers, according to a recent study.
A head-to-head study comparing five serological assays for SARS-CoV-2 antibodies showed that a commercial immunoassay by Siemens and a novel ELISA* test developed by the University of Oxford could achieve the desired sensitivity and specificity without further optimization — providing reassurance for their use.
A systematic review of randomized controlled trials (RCTs) has confirmed the potential of remdesivir in improving recovery and reducing serious adverse events (AEs), as well as mortality and time to clinical improvement, but not hospital length of stay, in coronavirus disease (COVID-19) patients.
Amid the pandemic of the novel coronavirus disease (COVID-19), healthcare workers in Asia are suffering from high rates of psychological distress, according to a recent study. The rates vary greatly across countries and seem to be independent of the case burden.